All good, happy to agree to disagree on that one. Invigo revenue received was from loans and those loans are still on the books therefore I have no reason to believe that it won't be recurring.
When it comes to more established companies I follow similar principles to you and I also look more deeply at the financials - free cash flow specifically as I tend to follow a value approach for larger companies. At the speculative end of the market I am more flexible in my approach as companies can pivot all over the place while they are finding their rhythm.
Anyway, as long as what you're doing works for you right?
All good, happy to agree to disagree on that one. Invigo revenue...
Add SPX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $38.92M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 0.9¢ | $6.453K | 655.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 6012211 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 1273575 | 5 |
View Market Depth
| Last trade - 14.17pm 02/08/2024 (20 minute delay) ? |
| SPX (ASX) Chart |